AcouSort extends collaboration with leading cell therapy company into a third project phase
AcouSort’s collaboration with the global life science company has reached yet another significant milestone with the signing of a Statement of Work (SoW) describing Phase 3 in the ongoing collaboration. The new assignment will generate revenues of at least SEK 485,000 in 2024.
Read the press release here.
Läs pressmeddelandet här.